IceCure Medical Statistics

Total Valuation

IceCure Medical has a market cap or net worth of $54.87 million. The enterprise value is $47.77 million.

Market Cap	54.87M
Enterprise Value	47.77M

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025, before market open.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

IceCure Medical has 56.57 million shares outstanding. The number of shares has increased by 11.48% in one year.

Current Share Class	56.57M
Shares Outstanding	56.57M
Shares Change (YoY)	+11.48%
Shares Change (QoQ)	+8.12%
Owned by Insiders (%)	49.28%
Owned by Institutions (%)	0.27%
Float	28.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.00
Forward PS	10.33
PB Ratio	7.95
P/TBV Ratio	7.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.07.

Current Ratio	1.95
Quick Ratio	1.45
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -160.70% and return on invested capital (ROIC) is -97.51%.

Return on Equity (ROE)	-160.70%
Return on Assets (ROA)	-67.69%
Return on Invested Capital (ROIC)	-97.51%
Return on Capital Employed (ROCE)	-222.26%
Revenue Per Employee	$49,864
Profits Per Employee	-$232,091
Employee Count	66
Asset Turnover	0.23
Inventory Turnover	0.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.91% in the last 52 weeks. The beta is 2.70, so IceCure Medical's price volatility has been higher than the market average.

Beta (5Y)	2.70
52-Week Price Change	-14.91%
50-Day Moving Average	1.21
200-Day Moving Average	0.95
Relative Strength Index (RSI)	32.97
Average Volume (20 Days)	230,816

Short Selling Information

The latest short interest is 240,290, so 0.42% of the outstanding shares have been sold short.

Short Interest	240,290
Short Previous Month	233,576
Short % of Shares Out	0.42%
Short % of Float	0.84%
Short Ratio (days to cover)	1.37

Income Statement

In the last 12 months, IceCure Medical had revenue of $3.29 million and -$15.32 million in losses. Loss per share was -$0.30.

Revenue	3.29M
Gross Profit	1.45M
Operating Income	-15.70M
Pretax Income	-14.49M
Net Income	-15.32M
EBITDA	-15.36M
EBIT	-15.70M
Loss Per Share	-$0.30

Full Income Statement

Balance Sheet

The company has $7.56 million in cash and $459,000 in debt, giving a net cash position of $7.11 million or $0.13 per share.

Cash & Cash Equivalents	7.56M
Total Debt	459,000
Net Cash	7.11M
Net Cash Per Share	$0.13
Equity (Book Value)	6.90M
Book Value Per Share	0.12
Working Capital	5.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.56 million and capital expenditures -$71,000, giving a free cash flow of -$12.63 million.

Operating Cash Flow	-12.56M
Capital Expenditures	-71,000
Free Cash Flow	-12.63M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	44.09%
Operating Margin	-476.94%
Pretax Margin	-465.45%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IceCure Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.48%
Shareholder Yield	-11.48%
Earnings Yield	-27.92%
FCF Yield	-23.02%

Analyst Forecast

The average price target for IceCure Medical is $2.50, which is 157.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.50
Price Target Difference	157.73%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	104.02%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IceCure Medical has an Altman Z-Score of -10.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.32
Piotroski F-Score	3